KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Capital Expenditures (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Capital Expenditures for 17 consecutive years, with $45.8 million as the latest value for Q4 2025.

  • Quarterly Capital Expenditures rose 6.76% to $45.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $157.6 million through Dec 2025, down 4.83% year-over-year, with the annual reading at $157.6 million for FY2025, 4.83% down from the prior year.
  • Capital Expenditures for Q4 2025 was $45.8 million at Bio-Rad Laboratories, up from $31.7 million in the prior quarter.
  • The five-year high for Capital Expenditures was $56.2 million in Q4 2021, with the low at $17.3 million in Q2 2022.
  • Average Capital Expenditures over 5 years is $36.3 million, with a median of $35.3 million recorded in 2022.
  • The sharpest move saw Capital Expenditures tumbled 38.04% in 2022, then surged 99.83% in 2023.
  • Over 5 years, Capital Expenditures stood at $56.2 million in 2021, then crashed by 38.04% to $34.8 million in 2022, then grew by 21.41% to $42.3 million in 2023, then rose by 1.5% to $42.9 million in 2024, then rose by 6.76% to $45.8 million in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $45.8 million, $31.7 million, and $45.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.